J
Jérémy Besnard
Researcher at University of Dundee
Publications - 13
Citations - 2170
Jérémy Besnard is an academic researcher from University of Dundee. The author has contributed to research in topics: Drug discovery & In vivo. The author has an hindex of 8, co-authored 12 publications receiving 1618 citations.
Papers
More filters
Journal ArticleDOI
Quantifying the chemical beauty of drugs
TL;DR: The utility of QED is extended by applying it to the problem of molecular target druggability assessment by prioritizing a large set of published bioactive compounds and may also capture the abstract notion of aesthetics in medicinal chemistry.
Journal ArticleDOI
Automated design of ligands to polypharmacological profiles
Jérémy Besnard,Gian Filippo Ruda,Vincent Setola,Keren Abecassis,Ramona M. Rodriguiz,Xi Ping Huang,Suzanne Norval,Maria F. Sassano,Antony I. Shin,Lauren A. Webster,Frederick R. C. Simeons,Laste Stojanovski,Annik Prat,Nabil G. Seidah,Daniel B. Constam,G. Richard J. Bickerton,Kevin D. Read,William C. Wetsel,Ian H. Gilbert,Bryan L. Roth,Andrew L. Hopkins +20 more
TL;DR: A new approach for the automated design of ligands against profiles of multiple drug targets, demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug into brain-penetrable ligands with either specific polypharmacology or exquisite selectivity profiles for G-protein-coupled receptors is described.
Journal ArticleDOI
Screening for GPCR Ligands Using Surface Plasmon Resonance.
TL;DR: The biosensor-based direct screening method identifies the interaction of both orthosteric and allosteric ligands with solubilized, native GPCRs, in a label-free and cell-free environment, thus overcoming the limitations of indirect and displacement assay methods.
Journal ArticleDOI
The Joint European Compound Library: boosting precompetitive research
TL;DR: The physicochemical profile and chemical diversity of the core collection of the JECL is analysed, showing that the collection is diverse and has a broad spectrum of predicted biological activity.
Patent
Design of molecules
Andrew L. Hopkins,Jérémy Besnard +1 more
TL;DR: A method for computational drug design using an evolutionary algorithm, comprises evaluating virtual molecules according to vector distance (VD) to at least one achievement objective that defines a desired ideal molecule as discussed by the authors.